Glencar has delivered a cutting-edge research, development, and manufacturing facility for Harwell Science and Innovation Campus, Oxfordshire—one of the UK’s leading scientific and technological innovation hubs.
The facility, set to become an Innovation and Technology Centre, is designed to drive the development and production of next-generation vaccines, and will play a pivotal role in strengthening the UK’s life sciences sector.
Commenting on the project completion, Roy Jones, Managing Director for London, and the South, said:
“We are immensely proud to have delivered this world-class facility, which will play a vital role in ensuring a secure and sustainable supply of vaccines for the UK. The successful completion of this project not only strengthens our partnership with Harwell but also reinforces Glencar’s reputation as a trusted contractor for high-end life sciences and pharmaceutical developments nationwide. The facility is a testament to our expertise in delivering complex R&D amenities, and we look forward to seeing the groundbreaking advancements that will take place within its walls.”
Jason Stafford, Development and Construction Director for Harwell Campus, said: “Working closely with Glencar, we’re delighted to have delivered a cutting-edge research and manufacturing facility. The development at Harwell will play a key role in UK pandemic preparedness by enabling the manufacture of tailored, innovative vaccines for the UK public.”
The completion of this facility reinforces Glencar’s partnership with Harwell Campus, and marks Glencar’s second major life sciences project for Harwell. A third project, Tech Edge West, is set to commence on the campus soon, providing flexible mid-tech space to attract cutting-edge research and development firms.
Beyond Harwell, Glencar is also currently delivering a 60,000 sq. ft fully fitted laboratory and office building at Chesterford Research Park in Cambridge for Aviva Investors, further cementing its credentials in the life sciences sector.
As demand for specialist laboratory and research space continues to surge, Glencar is playing a key role in shaping the future of life sciences infrastructure, supporting the UK’s ambition to lead in scientific research and innovation.
